Why Agile Therapeutics Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket

Gainers

ZyVersa Therapeutics, Inc. ZVSA shares rose 82.8% to $2.98 in pre-market trading. ZyVersa Therapeutics recently reported new employment inducement grants under Nasdaq Listing Rule 5635(c)(4).
Advent Technologies Holdings, Inc. ADN climbed 26.4% to $1.53 in pre-market trading. Hyundai Motor Company and Advent Technologies signed a joint development agreement following successful fuel cell technology assessment.
Boxed, Inc. BOXD gained 19% to $0.2140 in pre-market trading after gaining around 50% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S. Bankruptcy Code and other strategic alternatives.
YS Biopharma Co., Ltd. YS gained 16% to $8.11 in pre-market trading after dropping 8% on Wednesday.
China Jo-Jo Drugstores, Inc. CJJD shares rose 15.4% to $4.25 in pre-market trading after dropping more than 7% on Wednesday.
Agile Therapeutics, Inc. AGRX gained 14.3% to $0.3030 in pre-market trading following better-than-expected Q4 results.
Bellicum Pharmaceuticals, Inc. BLCM rose 13.8% to $0.33 in pre-market. Bellicum Pharmaceuticals shares fell over 8% on Wednesday after the company discontinued Phase 1/2 trials and initiated an evaluation of strategic alternatives.
Bird Global, Inc. BRDS shares rose 12.7% to $0.1360 in pre-market trading after dropping around 7% on Wednesday. Bird recently received additional funding, bringing total capital to $33 million this year.
Aziyo Biologics, Inc. AZYO rose 12.6% to $1.34 in pre-market trading after posting upbeat Q4 results.
Lion Group Holding Ltd. LGHL shares rose 12.1% to $0.2790 in pre-market trading after adding around 4% on Wednesday.

Losers

Minim, Inc. MINM fell 12.4% to $0.1375 in pre-market trading after gaining 17% on Wednesday. The company is expected to report Q4 results on March 29, 2023.
Heart Test Laboratories, Inc. HSCS shares dropped 8.7% to $0.95 in pre-market trading. Heart Test Laboratories, last week, posted a Q3 loss of $0.16 per share.
Coinbase Global, Inc. COIN fell 8.4% to $70.70 in pre-market trading after the company received a Wells Notice from the SEC alleging violations of federal securities laws in regards to the company's spot market and staking service.
VYNE Therapeutics Inc. VYNE fell 8.4% to $2.32 in pre-market after dropping more than 6% on Wednesday. VYNE Therapeutics recently posted a narrower-than-expected quarterly loss.
Fujian Blue Hat Interactive Entertainment Technology Ltd. BHAT fell 8% to $0.6716 in pre-market trading after gaining more than 13% on Wednesday.
Chewy, Inc. CHWY shares fell 6.6% to $35.26 in pre-market trading. Chewy reported better-than-expected earnings and sales results for its fourth quarter. However, the company's active customers came in at 20.4 million, down 1.2% from a year ago.
INVO Bioscience, Inc. INVO fell 6.4% to $0.7619 in pre-market trading after jumping over 28% on Wednesday. INVO recently signed binding agreements to acquire Wisconsin Fertility Institute.
Cidara Therapeutics, Inc. CDTX shares fell 6.3% to $1.78 in pre-market trading. Cidara Therapeutics and Melinta Therapeutics announced the FDA approval of REZZAYO for the treatment of candidemia and invasive candidiasis.
Sarcos Technology and Robotics Corporation STRC fell 6% to $0.40 in pre-market trading after gaining around 7% on Wednesday. Sarcos Technology recently posted upbeat quarterly results.
EZGO Technologies Ltd. EZGO fell 5% to $1.34 in pre-market trading after gaining over 33% on Wednesday.